# Maximizing the benefit and managing the risk of anti-amyloid monoclonal antibody therapy for Alzheimer's disease: Strategies and research directions

Review · Jeffrey L. Cummings

- Archive id: doi:10.1016/j.neurot.2025.e00570
- Published: 2025-03-20
- Venue: Neurotherapeutics
- DOI: https://doi.org/10.1016/j.neurot.2025.e00570
- PMID: 40118715
- Citations: 79
- Source URL: https://doi.org/10.1016/j.neurot.2025.e00570
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.